Skip to content

Closed-loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation

Comparison of Manual Propofol and Remifentanil Administration and Dual Closed-loop, Using Bispectral Index as the Control Variable, During Liver Transplantation

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00477347
Acronym
Drone-TH
Enrollment
5
Registered
2007-05-23
Start date
2007-05-31
Completion date
2009-09-30
Last updated
2016-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Keywords

Liver Transplantation, Anesthesia, general, Closed-loop

Brief summary

To compare closed-loop anesthesia to manual administration of propofol and remifentanil during liver transplantation

Detailed description

The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. We hypothesized that BIS can also indicate the adequacy of analgesia. Therefore we built a combined closed-loop anesthesia system using BIS as control variable and two proportional-differential control algorithms, a propofol and a remifentanil target-controlled infusion system. The effectiveness of such a closed-loop anesthesia system has been demonstrated in a prospective, randomized study. Elimination of anesthetic agents, propofol in particular, is strongly reduced during liver transplantation. Closed-loop anesthesia could provide adequacy for requirements in respect to the various phases of transplantation. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist, using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups the goal is to maintain BIS between 40 and 60, the range recommended by the manufacturer during anesthesia. We expect the combined closed-loop anesthesia system group to do better: i.e. diminished consumption of propofol (primary outcome measure).

Interventions

DEVICEClosed loop administration

intraoperative closed loop administration of propofol and remifentanil

DEVICEManual administration

intraoperative manual administration of propofol and remifentanil

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* liver transplantation

Exclusion criteria

* pregnant women * allergy to propofol or remifentanil, * neurological or muscular disorder, * liver encephalopathy, * patients taking psychotropic agents

Design outcomes

Primary

MeasureTime frame
consumption of propofol during anesthesia maintenanceduring anesthesia maintenance

Secondary

MeasureTime frame
- consumption of remifentanil - target modifications - hemodynamic events - volume loading and transfusion - extubation time, explicit memorization - time passed at BIS between 40 and 60 - MDAPE, wobble - global score - dysfunction of each system.during anesthesia maintenance

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026